Align Technology | ALGN - Umsatzerlöse

Aktienkurs
166.38
Täglich Wechseln
-10.95 -6.17%
Monatlich
-11.98%
Jährlich
4.50%
Q1 Prognose
161.39




Der Umsatz Veränderung Datum
3M USD 6.1B 200M 2025-12
Align Technology USD 1.05B 54.3M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Bruker USD 977.2M 116.7M 2025-12
Cardinal Health USD 65.63B 1.63B 2025-12
Charles River Laboratories USD 994.2M 5.8M 2025-12
Cooper Companies USD 1.02B 41.1M 2025-12
CVS Health USD 105.7B 2.8B 2025-12
Danaher USD 6.84B 790M 2025-12
Dentsply International USD 961M 57M 2025-12
Dexcom USD 1.26B 50M 2025-12
Henry Schein USD 3.4B 60M 2025-12
Idexx Laboratories USD 1.09B 10M 2025-12
Insulet USD 783.8M 77.5M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
IQVIA Holdings USD 4.36B 260M 2025-12
Masimo USD 412.5M 41M 2025-12
McKesson USD 106.16B 3.01B 2025-12
Mettler Toledo International USD 1.13B 100M 2025-12
Revvity USD 772.06M 73.06M 2025-12
Solventum Corp USD 1.99B 110M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Teleflex USD 568.98M 344.02M 2025-12
Thermo Fisher Scientific USD 12.21B 1.09B 2025-12
Veeva Systems USD 835.95M 24.72M 2025-12
Waters USD 932M 132M 2025-12
Zimmer Biomet Holdings USD 2.24B 240M 2025-12
Zoetis USD 2.4B 0 2025-12